These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 1320047)
1. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. Hellmér J; Marcus C; Sonnenfeld T; Arner P J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047 [TBL] [Abstract][Full Text] [Related]
2. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. Hellström L; Wahrenberg H; Reynisdottir S; Arner P J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252 [TBL] [Abstract][Full Text] [Related]
3. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells. Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164 [TBL] [Abstract][Full Text] [Related]
4. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet. Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398 [TBL] [Abstract][Full Text] [Related]
5. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819 [TBL] [Abstract][Full Text] [Related]
6. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells. Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970 [TBL] [Abstract][Full Text] [Related]
7. Is visceral adiposity a significant correlate of subcutaneous adipose cell lipolysis in men? Mauriège P; Brochu M; Prud'homme D; Tremblay A; Nadeau A; Lemieux S; Després JP J Clin Endocrinol Metab; 1999 Feb; 84(2):736-42. PubMed ID: 10022446 [TBL] [Abstract][Full Text] [Related]
8. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. Hoffstedt J; Arner P; Hellers G; Lönnqvist F J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094 [TBL] [Abstract][Full Text] [Related]
9. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying regional differences in lipolysis in human adipose tissue. Wahrenberg H; Lönnqvist F; Arner P J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539 [TBL] [Abstract][Full Text] [Related]
11. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters. Pecquery R; Leneveu MC; Giudicelli Y Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344 [TBL] [Abstract][Full Text] [Related]
12. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)]. Berlan M; Lafontan M; Dang Tran L J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915 [TBL] [Abstract][Full Text] [Related]
13. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects. Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030 [TBL] [Abstract][Full Text] [Related]
14. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives. Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214 [TBL] [Abstract][Full Text] [Related]
15. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. Marcus C; Karpe B; Bolme P; Sonnenfeld T; Arner P J Clin Invest; 1987 Jun; 79(6):1812-8. PubMed ID: 3034983 [TBL] [Abstract][Full Text] [Related]
16. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959 [TBL] [Abstract][Full Text] [Related]
17. Effects of lipolytic and antilipolytic agents on glucose transport in human fat cells. Arner P; Goldinger M; Marcus C; Engfeldt P Int J Obes; 1991 May; 15(5):327-31. PubMed ID: 1653187 [TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional beta 3-adrenoceptor in man. Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344 [TBL] [Abstract][Full Text] [Related]
19. Adipose tissue metabolism in young and middle-aged men after control for total body fatness. Imbeault P; Prud'Homme D; Tremblay A; Després JP; Mauriège P J Clin Endocrinol Metab; 2000 Jul; 85(7):2455-62. PubMed ID: 10902793 [TBL] [Abstract][Full Text] [Related]
20. Omental and epigastric adipose tissue lipolytic activity in human obesity. Effect of abdominal fat distribution and relationship with hyperinsulinemia. Busetto L; Digito M; Dalla Montá P; Carraro R; Enzi G Horm Metab Res; 1993 Jul; 25(7):365-71. PubMed ID: 8406322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]